Mario Valenti

Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050

Mohsen Naghavi, Kevin S Ikuta, Lucien R Swetschinski et al. · The Lancet · 2024 · 2.2K citations · Full text

Global Burden, Antimicrobial Susceptibility, Antimicrobial Stewardship +12

Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Michael Bräuer, Gregory A. Roth, Aleksandr Y. Aravkin et al. · The Lancet · 2024 · 2.1K citations · Full text

Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study

Riccardo G. Borroni, Piergiorgio Malagoli, Luigi Gargiulo et al. · Acta Dermato Venereologica · 2021 · 44 citations · Full text

Autoimmune Disease, Immunodeficiencies, Immunology +12

Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021

Haley Comfort, Theresa A. McHugh, Austin E Schumacher et al. · The Lancet · 2024 · 43 citations · Full text

Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—<scp>IL PSO</scp> (<scp>Italian landscape psoriasis</scp>)

Alessandra Narcisi, Mario Valenti, Luigi Gargiulo et al. · Journal of the European Academy of Dermatology and Venereology · 2022 · 41 citations · Full text